Use of whole genome sequencing to identify low-frequency mutations in COVID-19 patients treated with remdesivir https://www.medrxiv.org/content/10.1101/2022.11.20.22282552
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.